Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Benchuan Wu is active.

Publication


Featured researches published by Benchuan Wu.


Journal of Bioscience and Bioengineering | 2004

Temperature shift as a process optimization step for the production of pro-urokinase by a recombinant Chinese hamster ovary cell line in high-density perfusion culture

Zhaolie Chen; Benchuan Wu; Hong Liu; Xingmao Liu; Peitang Huang

Based on the effects of temperature shift on the cell cycle, apoptosis and metabolism of a recombinant Chinese hamster ovary (rCHO) cell line (CL-11G) producing pro-urokinase (pro-UK) in batch cultures, the potential of temperature shift as a tool in the optimization of the perfusion culture of CL-11G cells for the production of pro-UK was examined. The proportion of CL-11G cells in the G0/G1 phase in static cultures increased from 56.4% to 82.8% following a temperature shift from 37 degrees C to 31 degrees C. Conversely, the proportion of CL-11G cells in the S phase decreased from 34.8% to 11.6%. The specific growth rate of CL-11G cells reflected the effect of temperature on the cell cycle and decreased from 0.024 h(-1) at 37 degrees C to 0.006 h(-1) at 31 degrees C. Continuous exposure to the non-permissive temperature of 31 degrees C led to a marginal increase in apoptosis. The specific pro-UK productivity of CL-11G cells increased by 74% at 34 degrees C compared with controls at 37 degrees C in batch cultures. CL-11G cells immobilized with Cytopore 1 in a 5-l bioreactor initiated at 37 degrees C and temperature shifted to 34 degrees C exhibited an average 17% increase in viable cell density and an average 47% increase in pro-UK production. These results demonstrated that temperature shift offers the prospect of enhancing the productivity of pro-UK in high-density perfusion culture.


Journal of Bioscience and Bioengineering | 2009

A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates

Hong Liu; Xingmao Liu; Shichong Li; Benchuan Wu; Lingling Ye; Qiwei Wang; Zhaolie Chen

Cells of the human embryonic kidney cell line (HEK 293) were grown as suspended aggregates in stirred vessels and infected with a recombinant adenovirus vector (Ad-TH-GFP). Regular spherical aggregates with the mean diameter less than 300 microm and a viable cell density greater than 5 x 10(6) cells x ml(-1) were readily achieved after 9 day culture in spinner flasks. The HEK 293 cells growing as suspended aggregates could be efficiently infected by Ad-TH-GFP at an MOI of 10 with a prolonging infection time up to 144 hour post-infection (hpi). The time profile of Ad-TH-GFP production was strongly corresponding to the infection process with a virus concentration peak occurred consistently at 144 h after infection. And the infected aggregates essentially maintained spherical in shape, the portion of dissociated cells from the infected aggregates was less than 5% at 144 hpi. Perfusion culture of HEK 293 cells grown as suspended aggregates in a 7.5 L stirred tank bioreactor and infected with Ad-TH-GFP at a density higher than 1 x 10(7) cells x ml(-1) resulted in a similar Ad-TH-GFP production kinetics, but a much higher virus yield approximately at 5.7 x 10(11) GTU ml(-1) at 144 hpi to that of the infected spinner flask cultures. These results demonstrate the feasibility for using suspended cell aggregates as an immobilization system to facilitate perfusion in stirred tank bioreactors, and improve volumetric productivities by eliminating the cell density effect.


Journal of Heart and Lung Transplantation | 2012

Construction of vascularized cardiac tissue from genetically modified mouse embryonic stem cells

Wenjun He; Lingling Ye; Shichong Li; Hong Liu; Benchuan Wu; Qiwei Wang; Xiaobing Fu; Weidong Han; Zhaolie Chen

BACKGROUND The aim of myocardial tissue engineering is to repair or regenerate damaged myocardium with engineered cardiac tissue constructed by a combination of cells and scaffolds in vitro. However, this strategy has been hampered by the lack of cardiomyocytes and the significant cell death after transplantation in vivo. METHODS In this study we explored the feasibility of in vitro construction of vascularized cardiac muscle using genetically modified mouse embryonic stem cells (ESCs) transfected by pMHC-neo/SV40-hygro. A stirred bioreactor was used to facilitate the formation of a large number of ESC-derived cardiomyocytes, which were then mixed with human umbilical vein endothelial cells (HUVECs) and mouse embryonic fibroblasts (MEFs) in a liquid collagen scaffold to construct highly vascularized cardiac tissue in vitro. RESULTS The resulting tissue constructs were transplanted into dorsal subcutaneous sites of nude mice. Tumor formation was not detected in all samples and vascularized cardiac tissue could survive after transplantation. Vascularization of the implanted cardiac muscle was significantly enhanced by the addition of HUVECs and MEFs, which resulted in a thicker myocardium. The combination of genetically modified ESCs and stirred bioreactor cultivation not only benefited the large-scale production of pure ESC-derived cardiomyocytes, but also effectively controlled the potential risk of undifferentiated ESCs. CONCLUSIONS Using liquid collagen as scaffold, the enriched cardiomyocytes derived from genetically modified ESCs mixed with HUVECs and MEFs in 3-dimensional culture resulted in highly vascularized cardiac tissues.


Chinese Journal of Biotechnology | 2007

Enhancement of Exogenous Gene Expression by the Artificial Transcription Factor in Chinese Hamster Ovary Cells

Shichong Li; Lingling Ye; Huanming Yang; Hong Liu; Xu J; Benchuan Wu; Peitang Huang; Zhaolie Chen

Abstract Using the amino acids 1-147 of the yeast transcriptional activator GAL4 as the DNA-binding domain and four tandem repeats of the 12-aa peptide (DALDDFDLDMLG) of the herpesvirus VP16 as the activation domain, an artificial transcription factor, GVP4 was constructed via the linkage of the nuclear localization signal sequence of SV40. And then, GVP4 was cloned into expression vector pcDNA3.1/Hygro(+). Various amounts of targeting sites of artificial transcription factor were linked to the upstream of promoter CMV in exogenous gene expression vector pcDNA3.1(+) that separately harbored EGFP cDNA and t-PA cDNA. The CHO cells were co-transfected with GVP4 expression vector and EGFP or t-PA expression vector. The effect of GVP4 on exogenous gene expression was evaluated by measuring the fluorescence intensity of EGFP in CHO cells and the concentration of t-PA in the supernatant. GVP4 showed positive effect on enhancement of exogenous gene expression in CHO cells integrated with targeting sites of artificial transcription factor. And, CHO cells integrated with 10 targeting sites of GVP4 was more favorable to foreign gene expression, which resulted in 2-3-fold increase in both EGFP and t-PA expressions. These results indicated that artificial transcription factor is potent in the enhancement of exogenous gene expression in mammalian cells.


Chinese Journal of Biotechnology | 2006

In vitro Cytolysis of B-lymphoma Cells Mediated by an Anti-CD3/Anti-CD20 Bispecific Single-chain Antibody

Yu R; Shichong Li; Benchuan Wu; Hong Liu; Lingling Ye; Xingmao Liu; Qiwei Wang; Zhaolie Chen

After having successfully constructed and expressed the gene of the anti-CD3/anti-CD20 bispecific single-chain antibody (bscCD3 x CD20), here we analyzed its in vitro bioactivity of mediating the lysis of Ramous human B-lymphoma cells in the presence of T-enriched human peripheral blood lymphocytes (PBL). Obvious opoptosis characters were observed by Annexin V/PI(AV/PI) stained and scanning electron microscope. As evaluated by non-radioactive cytotoxity assay, the bscCD3 x CD20 showed potent bioactivity of mediating human B-lymphoma cells lysis in the presence of T-enriched human PBL. The potency of cytotoxicity depended on the ratios of effect cells to target cells (E:T) used. Further, the antibody showed a dose and time-dependent effect on mediating Ramous cells lysis. The specific lysis reached about 87.3% at an antibody concentration of 5microg/mL and E:T used at 10:1. Clear changes in apoptogenes expression profiles were detected by apoptosis gene array after Ramous cells were treated with the antibody and PBL. Among the upregulated apoptogenes, ATM and P53 showed an increase of 187 times and 15 times respectively, which suggested that ATM-p53 pathway may be the main apoptosis way of Ramous cells induced by T cells in the presence of the bscCD3 x CD20.


Journal of Bioscience and Bioengineering | 2006

Cultivation of Recombinant Chinese hamster ovary cells grown as suspended aggregates in stirred vessels

Yi Han; Xingmao Liu; Hong Liu; Shichong Li; Benchuan Wu; Lingling Ye; Qu-Wei Wang; Zhaolie Chen


Biotechnology Techniques | 1998

Hyperosmolality leads to an increase in tissue-type plasminogen activator production by a Chinese hamster ovary cell line

Zhaolie Chen; Hong Liu; Benchuan Wu


Archive | 2012

Serum-free culture medium without animal origin components for culturing Vero cell micro-carrier

Zhaolie Chen; Shichong Li; Hong Liu; Xingmao Liu; Qiwei Wang; Benchuan Wu; Lingling Ye


Chinese Journal of Biotechnology | 1996

Study on serum-free media for genetically engineered CHO cells producing prourokinase.

Zhi-Nan Chen; Benchuan Wu; Jia X; Hong Liu; Xiao C


Archive | 2011

Blood serum-free culture medium for supporting suspension culture of CHO cells with large scale and high density

Zhaolie Chen; Shichong Li; Hong Liu; Xingmao Liu; Qiwei Wang; Benchuan Wu; Jing Xie; Lingling Ye

Collaboration


Dive into the Benchuan Wu's collaboration.

Top Co-Authors

Avatar

Hong Liu

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Lingling Ye

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Zhaolie Chen

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Shichong Li

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Xingmao Liu

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Qiwei Wang

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Zhi-Nan Chen

Fourth Military Medical University

View shared research outputs
Top Co-Authors

Avatar

Hongwei Liu

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Yu R

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Huanming Yang

Beijing Genomics Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge